Disruptions in a protein-processing pathway appear to promote aggressive proliferation and invasion in tumor cells

January 29, 2014, Agency for Science, Technology and Research (A*STAR), Singapore
A misdirection that fuels cancer growth
Cells from breast tumor biopsies show abnormally high accumulation of Tn-modified proteins in the endoplasmic reticulum (ER). Tn localizes in the ER in breast cancer cells (left, white), as indicated by labeling of the ER (right, white). Cell nuclei stained blue. Credit: Gill et al.

Many proteins at the cell surface are 'decorated' with carbohydrate molecules called glycans. Changes in a cell's glycan profile can greatly alter how it behaves and interacts with its environment, and abnormalities in this process are a common feature of cancer cells. Researchers led by Frederic Bard of the A*STAR Institute of Molecular and Cell Biology in Singapore have now uncovered a potentially critical link between the glycan addition process and invasive tumor growth.

Cancer often produce abnormally high levels of proteins modified with a glycan precursor known as Tn. In healthy cells, newly translated proteins are processed in a structure called the endoplasmic reticulum (ER) before moving on to the Golgi apparatus. Within the Golgi, proteins receive the Tn modification from enzymes known as GalNAc-Ts, and Tn is subsequently transformed into more complex glycans by other Golgi enzymes. Scientists have long assumed that experience defects in this latter pathway, which ultimately directs excess Tn-modified proteins to the .

Bard and David Gill, however, arrived at an alternative hypothesis. In previous research, they determined that Src, a signaling overactive in many cancers, can cause GalNAc-Ts to relocate from the Golgi to the ER. They subsequently determined that the presence of GalNAc-Ts in the ER is sufficient to induce a sharp elevation in Tn levels. Contrary to expectations, Tn in cultured cells was largely retained within the ER rather than being transported to the cell surface. The researchers observed similar behavior in a diverse array of hundreds of tumor samples (see image).

When Bard and co-workers examined tumor cell lines that had been genetically modified to forcibly shift GalNAc-T localization to the ER, they observed that this made the cells far more aggressive and prone to invasive growth. "The most surprising finding was how readily ER glycosylation stimulates cell migration and cell adhesion," says Bard. "It seems counterintuitive that modifications occurring inside the ER would produce dramatic changes in how the cell interacts with its environment."

Bard and his co-workers hypothesize that these effects are driven by proteins that escape directly to the cell surface after undergoing Tn modification in the ER. By exploring this question in future work, Bard aims to uncover vulnerabilities that could be exploited to disrupt the tumor growth machinery. "We expect that this Src-mediated pathway is activated in 60 to 80 per cent of human tumors and so any benefits could apply to a lot of patients," he says.

Explore further: High-resolution 3-D imaging draws new picture of Golgi's whereabouts during cell division

More information: Gill, D. J., Tham, K. M., Chia, J., Wang, S. C., Steentoft, C. et al. Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. Proceedings of the National Academy of Sciences USA 110, E3152–E3161 (2013). dx.doi.org/%20%20%20%2010.1073/pnas.1305269110

Gill, D. J., Chia, J., Senewiratne, J. & Bard, F. Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. The Journal of Cell Biology 189, 843–858 (2010). dx.doi.org/10.1083/jcb.201003055

Related Stories

High-resolution 3-D imaging draws new picture of Golgi's whereabouts during cell division

December 15, 2013
Resolving a fundamental question in cell biology and showing off the powers of new high-resolution 3-D imaging, NIH scientists have discovered where the Golgi apparatus, which sorts newly synthesized proteins for transport ...

Cellular 'stress sensor' that also modulates metabolism could offer therapeutic target for diabetes

July 31, 2013
An organelle called the endoplasmic reticulum (ER) helps to process newly synthesized proteins destined for delivery to the cell membrane. When the ER becomes overloaded and begins to accumulate poorly folded proteins, an ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.